Zusammenfassung
Epilepsien nach „Schlaganfällen“ repräsentieren ca. 20% aller Epilepsien im Erwachsenenalter. Häufig scheinen die Patienten selber eine Amnesie für ihre epileptischen Anfälle zu haben, die symptomarm verlaufen können. Postiktal wurden Tage andauernde Todd-Paresen und Verwirrtheitszustände beschrieben, die die Diagnose weiter erschweren können. Einzelne epileptische Anfälle wurden nach Schlaganfällen in 2–10% der Fälle beobachtet, während populationsbasierte Studien eine Epilepsierate von 3–4% angegeben. Subgruppenanalysen ergaben nach ischämischen Hirninfarkten eine Häufigkeit von Epilepsien von ca. 3%, nach intrazerebralen Blutungen von 6–10% und nach Subarachnoidalblutungen (SAB) von ca. 9%. Ein Status epilepticus entwickelte sich nach einem Schlaganfall in weniger als 1%. Hinsichtlich Diagnose und Behandlung weisen Epilepsien nach Schlaganfällen Besonderheiten auf, die in der Übersichtsarbeit näher dargestellt werden. Die Prognose von Epilepsien nach Schlaganfällen ist mit Anfallsfreiheitsraten von 67 und 54% günstig.
Abstract
Epilepsies after stroke represent about 20% of all adult onset epilepsies. The patients are frequently amnestic about having the seizures, which can be very subtle. Postictal pareses and confusional states can last for days, which further complicate diagnosis. Single seizures after stroke were reported in 2–10% of cases and community-based studies report epilepsies in 3–4% of stroke patients. Analyses of subgroups identified a 3% risk of epilepsies after ischemic infarction, a risk of 6–10% after intracerebral hemorrhages, and a 9% risk after subarachnoid hemorrhages. Status epilepticus developed in less than 1% of stroke patients. Concerning diagnosis and treatment, epilepsies after stroke tend to have specific features as described in the article. The prognosis of post-stroke epilepsies is good. Prospective studies reported seizure-free rates of 67 and 54%.
Literatur
Forsgren L, Beghi E, Oun A et al (2005) The epidemiology of epilepsy in Europe – a systematic review. Eur J Neurol 12:245–253
Karhunen H, Jolkkonen J, Sivenius J et al (2005) Epileptogenesis after experimental focal cerebral ischemia. Neurochem Res 30:1529–1542
Hauser WA, Annegers JF, Kurland LT (1993) Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota 1935–1984. Epilepsia 34:453–468
Ramsay RE, Rowan AJ, Pryor FM (2004) Special considerations in treating the elderly patient with epilepsy. Neurology 62:S24–S29
Hamer HM (2009) Epileptische Anfälle und Epilepsien nach „Schlaganfällen“. Nervenarzt 80:405–414
Lüders H, Acharya J, Baumgartner C et al (1998) Semiological seizure classification. Epilepsia 39:1006–1013
Ferro JM, Pinto F (2004) Poststroke epilepsy: epidemiology, pathophysiology and management. Drugs Aging 21:639–653
Gallmetzer P, Leutmezer F, Serles W et al (2004) Postictal paresis in focal epilepsies – incidence, duration and causes: a video-EEG monitoring study. Neurology 62:2160–2164
Godfrey JW, Roberts MA, Caird FI (1982) Epileptic seizures in the elderly: II. Diagnostic problems. Age Ageing 11:29–34
Blum DE, Eskola J, Bortz JJ et al (1996) Patient awareness of seizures. Neurology 47:260–264
Ryvlin P, Montavont A, Nighoghossian N (2006) Optimizing therapy of seizures in stroke patients. Neurology 67:S3–S9
Carrera E, Michel P, Despland PA et al (2006) Continuous assessment of electrical epileptic activity in acute stroke. Neurology 67:99–104
Holmes GL (1980) The electroencephalogram as a predictor of seizures following cerebral infarction. Clin Electroencephalogr 11:83–86
Davenport RJ, Dennis MS, Wellwood I et al (1996) Complications after acute stroke. Stroke 27:415–420
Myint PK, Staufenberg EF, Sabanathan K (2006) Post-stroke seizure and post-stroke epilepsy. Postgrad Med J 82:568–572
Lossius MI, Ronning OM, Slapo GD et al (2005) Poststroke epilepsy: occurrence and predictors – a long-term prospective controlled study (Akershus Stroke Study). Epilepsia 46:1246–1251
Naess H, Nyland HI, Thomassen L et al (2004) Long-term outcome of cerebral infarction in young adults. Acta Neurol Scand 110:107–112
Burn J, Dennis M, Bamford J et al (1997) Epileptic seizures after a first stroke: the Oxfordshire Community Stroke Project. BMJ 315:1582–1587
So EL, Annegers JF, Hauser WA et al (1996) Population-based study of seizure disorders after cerebral infarction. Neurology 46:350–355
Giroud M, Gras P, Fayolle H et al (1994) Early seizures after acute stroke: a study of 1,640 cases. Epilepsia 35:959–964
Kammersgaard LP, Olsen TS (2005) Poststroke epilepsy in the Copenhagen stroke study: incidence and predictors. J Stroke Cerebrovasc Dis 14:210–214
Benbir G, Ince B, Bozluolcay M (2006) The epidemiology of post-stroke epilepsy according to stroke subtypes. Acta Neurol Scand 114:8–12
Bladin CF, Alexandrov AV, Bellavance A et al (2000) Seizures after stroke: a prospective multicenter study. Arch Neurol 57:1617–1622
Lamy C, Domigo V, Semah F et al (2003) Early and late seizures after cryptogenic ischemic stroke in young adults. Neurology 60:400–404
Claassen J, Peery S, Kreiter KT et al (2003) Predictors and clinical impact of epilepsy after subarachnoid hemorrhage. Neurology 60:208–214
Cervoni L, Artico M, Salvati M et al (1994) Epileptic seizures in intracerebral hemorrhage: a clinical and prognostic study of 55 cases. Neurosurg Rev 17:185–188
Kilpatrick CJ, Davis SM, Tress BM et al (1990) Epileptic seizures in acute stroke. Arch Neurol 47:157–160
Kilpatrick CJ, Davis SM, Hopper JL et al (1992) Early seizures after acute stroke. Risk of late seizures. Arch Neurol 49:509–511
Schulz UG, Rothwell PM (2002) Transient ischaemic attacks mimicking focal motor seizures. Postgrad Med J 78:246–247
Rumbach L, Sablot D, Berger E et al (2000) Status epilepticus in stroke: report on a hospital-based stroke cohort. Neurology 54:350–354
Waterhouse EJ, Vaughan JK, Barnes TY et al (1998) Synergistic effect of status epilepticus and ischemic brain injury on mortality. Epilepsy Res 29:175–183
Claassen J, Bateman BT, Willey JZ et al (2007) Generalized convulsive status epilepticus after nontraumatic subarachnoid hemorrhage: the nationwide inpatient sample. Neurosurgery 61:60–64
Knake S, Rochon J, Fleischer S et al (2006) Status epilepticus after stroke is associated with increased long-term case fatality. Epilepsia 47:2020–2026
Afsar N, Kaya D, Aktan S et al (2003) Stroke and status epilepticus: stroke type, type of status epilepticus, and prognosis. Seizure 12:23–27
Devinsky O, Kelley K, Porter RJ et al (1988) Clinical and electroencephalographic features of simple partial seizures. Neurology 38:1347–1352
Sacquegna T, de Carolis P, Crisci M et al (1995) Status epilepticus in acute ischemic stroke. Ital J Neurol Sci 16:453–457
Berges S, Moulin T, Berger E et al (2000) Seizures and epilepsy following strokes: recurrence factors. Eur Neurol 43:3–8
Lancman ME, Golimstok A, Norscini J et al (1993) Risk factors for developing seizures after a stroke. Epilepsia 34:141–143
Sung CY, Chu NS (1990) Epileptic seizures in thrombotic stroke. J Neurol 237:166–170
Paolucci S, Silvestri G, Lubich S et al (1997) Poststroke late seizures and their role in rehabilitation of inpatients. Epilepsia 38:266–270
Heuts-van Raak L, Lodder J, Kessels F (1996) Late seizures following a first symptomatic brain infarct are related to large infarcts involving the posterior area around the lateral sulcus. Seizure 5:185–194
Luhdorf K, Jensen LK, Plesner AM (1986) Etiology of seizures in the elderly. Epilepsia 27:458–463
Misirli H, Ozge A, Somay G et al (2006) Seizure development after stroke. Int J Clin Pract 60:1536–1541
Camilo O, Goldstein LB (2004) Seizures and epilepsy after ischemic stroke. Stroke 35:1769–1775
Pohlmann-Eden B, Fatar M, Hennerici M (2001) The preserved cortical island sign is highly predictive of postischemic seizures. Cerebrovasc Dis 12:282
De Reuck J, Hemelsoet D, Van Maele G (2007) Seizures and epilepsy in patients with a spontaneous intracerebral haematoma. Clin Neurol Neurosurg 109:501–504
De Reuck J, Goethals M, Vonck K et al (2005) Clinical predictors of late-onset seizures and epilepsy in patients with cerebrovascular disease. Eur Neurol 54:68–72
Arboix A, Comes E, Garcia-Eroles L et al (2003) Prognostic value of very early seizures for in-hospital mortality in atherothrombotic infarction. Eur Neurol 50:78–84
Barolin GS, Scherzer E, Schnaberth G (1971) Epileptic manifestations as precursors of apoplexies. Vascular precursive epilepsy. Fortschr Neurol Psychiatr Grenzgeb 39:199–216
Cleary P, Shorvon S, Tallis R (2004) Late-onset seizures as a predictor of subsequent stroke. Lancet 363:1184–1186
Frisher S, Herishanu YO (1987) Frequency of epilepsy preceding stroke. Lancet 2:393
Labovitz DL, Hauser WA, Sacco RL (2001) Prevalence and predictors of early seizure and status epilepticus after first stroke. Neurology 57:200–206
Reith J, Jorgensen HS, Nakayama H et al (1997) Seizures in acute stroke: predictors and prognostic significance. The Copenhagen Stroke Study. Stroke 28:1585–1589
Vespa PM, O’Phelan K, Shah M et al (2003) Acute seizures after intracerebral hemorrhage: a factor in progressive midline shift and outcome. Neurology 60:1441–1446
Vernino S, Brown RD Jr, Sejvar JJ et al (2003) Cause-specific mortality after first cerebral infarction: a population-based study. Stroke 34:1828–1832
Bogousslavsky J, Martin R, Regli F et al (1992) Persistent worsening of stroke sequelae after delayed seizures. Arch Neurol 49:385–388
Kwan J, Guenther A (2006) Antiepileptic drugs for the primary and secondary prevention of seizures after intracranial venous thrombosis. Cochrane Database Syst Rev 3:CD005501
Ringleb R, Schellinger PD, Hacke W (2008) Leitlinien zum Management von Patienten mit akutem Hirninfarkt oder TIA 2008 der Europäischen Schlaganfall Organisation (ESO). http://www.eso-stroke.org. Gesehen 09.08.2008
Adams HP Jr, del Zoppo G, Alberts MJ et al (2007) Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council and the Atherosclerotic peripheral vascular disease and quality of care outcomes in research interdisciplinary working groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 38:1655–1711
Steiner T, Kaste M, Forsting M et al (2006) Recommendations for the management of intracranial haemorrhage. Part I: spontaneous intracerebral haemorrhage. The European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee. Cerebrovasc Dis 22:294–316
Broderick J, Connolly S, Feldmann E et al (2007) Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke 38:2001–2023
Passero S, Rocchi R, Rossi S et al (2002) Seizures after spontaneous supratentorial intracerebral hemorrhage. Epilepsia 43:1175–1180
Gilad R, Lampl Y, Eschel Y et al (2001) Antiepileptic treatment in patients with early postischemic stroke seizures: a retrospective study. Cerebrovasc Dis 12:39–43
Herman ST (2002) Epilepsy after brain insult: targeting epileptogenesis. Neurology 59:S21–S26
Fisher RS, van Emde BW, Blume W et al (2005) Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 46:470–472
Naidech AM, Kreiter KT, Janjua N et al (2005) Phenytoin exposure is associated with functional and cognitive disability after subarachnoid hemorrhage. Stroke 36:583–587
Goldstein LB (1995) Common drugs may influence motor recovery after stroke. The Sygen in Acute Stroke Study Investigators. Neurology 45:865–871
Brailowsky S, Knight RT, Efron R (1986) Phenytoin increases the severity of cortical hemiplegia in rats. Brain Res 376:71–77
Schallert T, Hernandez TD, Barth TM (1986) Recovery of function after brain damage: severe and chronic disruption by diazepam. Brain Res 379:104–111
Haffner S, Thurmann PA (2004) Which drug interactions the general practitioner should know. Med Klin 99:137–146
Fraser DG, Ludden TM, Evens RP et al (1980) Displacement of phenytoin from plasma binding sites by salicylate. Clin Pharmacol Ther 27:165–169
Schlienger R, Kurmann M, Drewe J et al (2000) Inhibition of phenprocoumon anticoagulation by carbamazepine. Eur Neuropsychopharmacol 10:219–221
Stephen LJ (2003) Drug treatment of epilepsy in elderly people: focus on valproic acid. Drugs Aging 20:141–152
Ragueneau-Majlessi I, Levy RH, Meyerhoff C (2001) Lack of effect of repeated administration of levetiracetam on the pharmacodynamic and pharmacokinetic profiles of warfarin. Epilepsy Res 47:55–63
Boon P, Hulhoven R, Offner F (2007) Levetiracetam and bleeding disorders. Acta Neurol Belg 107:97–102
Kramer G, Tettenborn B, Klosterskov Jensen P et al (1992) Oxcarbazepine does not affect the anticoagulant activity of warfarin. Epilepsia 33:1145–1148
Lyseng-Williamson KA, Yang LP (2007) Topiramate: a review of its use in the treatment of epilepsy. Drugs 67:2231–2256
Bialer M (2005) The pharmacokinetics and interactions of new antiepileptic drugs: an overview. Ther Drug Monit 27:722–726
Silverman IE, Restrepo L, Mathews GC (2002) Poststroke seizures. Arch Neurol 59:195–201
Patsalos PN, Perucca E (2003) Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs. Lancet Neurol 2:473–481
Pack A (2008) Bone health in people with epilepsy: is it impaired and what are the risk factors? Seizure 17:181–186
Alvarez-Sabin J, Montaner J, Padro L et al (2002) Gabapentin in late-onset poststroke seizures. Neurology 59:1991–1993
Gilad R, Sadeh M, Rapoport A et al (2007) Monotherapy of lamotrigine versus carbamazepine in patients with poststroke seizure. Clin Neuropharmacol 30:189–195
Brodie MJ, Overstall PW, Giorgi L (1999) Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group. Epilepsy Res 37:81–87
Rowan AJ, Ramsay RE, Collins JF et al (2005) New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology 64:1868–1873
Saetre E, Perucca E, Isojarvi J et al (2007) An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly. Epilepsia 48:1292–1302
Groselj J, Guerrini R, Van Oene J et al (2005) Experience with topiramate monotherapy in elderly patients with recent-onset epilepsy. Acta Neurol Scand 112:144–150
Mauri Llerda JA, Tejero C, Mercade JM et al (2005) Lamotrigine and epilepsy in the elderly: observational study of low-dose monotherapy. Int J Clin Pract 59:651–654
Kutluay E, McCague K, D’Souza J et al (2003) Safety and tolerability of oxcarbazepine in elderly patients with epilepsy. Epilepsy Behav 4:175–180
Ferrendelli JA, French J, Leppik I et al (2003) Use of levetiracetam in a population of patients aged 65 years and older: a subset analysis of the KEEPER trial. Epilepsy Behav 4:702–709
Glauser T, Ben Menachem E, Bourgeois B et al (2006) ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 47:1094–1120
Nieto-Barrera M, Brozmanova M, Capovilla G et al (2001) A comparison of monotherapy with lamotrigine or carbamazepine in patients with newly diagnosed partial epilepsy. Epilepsy Res 46:145–155
Arroyo S, Kramer G (2001) Treating epilepsy in the elderly: safety considerations. Drug Saf 24:991–1015
Stephen LJ, Kwan P, Brodie MJ (2001) Does the cause of localisation-related epilepsy influence the response to antiepileptic drug treatment? Epilepsia 42:357–362
Semah F, Picot MC, Adam C et al (1998) Is the underlying cause of epilepsy a major prognostic factor for recurrence? Neurology 51:1256–1262
Gupta SR, Naheedy MH, Elias D et al (1988) Postinfarction seizures. A clinical study. Stroke 19:1477–1481
Interessenkonflikt
Der korrespondierende Autor weist auf folgende Beziehung/en hin: Berater- und/oder Vortragshonorare von Desitin Arzneimittel GmbH, Eisai GmbH, GSK GmbH & Co.KG, Novartis GmbH, Pfizer Pharma GmbH, UCB GmbH.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hamer, H. Epileptische Anfälle und Epilepsien nach „Schlaganfällen“. Z. Epileptol. 22, 72–79 (2009). https://doi.org/10.1007/s10309-009-0033-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10309-009-0033-1